PIGS
protein-codingphosphatidylinositol glycan anchor biosynthesis class S, the group of Glycosylphosphatidylinositol transamidase complex|Phosphatidylinositol glycan anchor biosynthesis
Gene summary
This gene encodes a protein that is involved in GPI-anchor biosynthesis. The glycosylphosphatidylinositol (GPI) anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes an essential component of the multisubunit enzyme, GPI transamidase. GPI transamidase mediates GPI anchoring in the endoplasmic reticulum, by catalyzing the transfer of fully assembled GPI units to proteins. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~18.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0029140
Submitter: ClinGen
*PIGS* was first reported in relation to autosomal recessive developmental and epileptic encephalopathy 95 (MONDO:0029140) in 2018 (Nguyen TTM et al., PMID:30269814). This condition is caused by variants in the *PIGS* gene, which encodes an essential component of the multisubunit enzyme, GPI transamidase. GPI transamidase mediates GPI anchoring in the endoplasmic reticulum, by catalyzing the transfer of fully assembled GPI units to proteins. [provided by RefSeq, Jul 2008]. 87 unique variants (e.g., synonymous, missense, in-frame indel, nonsense, frameshift) have been reported in humans by ClinVar; 13 of these variants are classified as pathogenic or likely pathogenic in ClinVar. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Eleven variants that have been reported in 9 probands in 3 publications (Nguyen TTM et al., 2018, PMID:30269814; Efthymiou S et al., 2021, PMID:33410539; Zhang L et al., 2020, PMID:32612635), are included in this curation. This gene-disease relationship is also supported by the protein interactions of the protein; *PIGS*, with GPI8, GAA1, and *PIG‑T *to form a stable, multi-component enzyme complex essential for the biochemical process of GPI anchoring. (Ohishi K et al., 2001, PMID:11483512). In summary, there is definitive evidence to support this gene-disease relationship. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Congenital Disorder of Glycosylation GCEP on the meeting date May 21, 2025 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0029140
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0029140
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0029140
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0029140
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic
Intervention: Neurologic
Rationale: Among other manifestations, individuals may have difficult-to-control seizures, and management with oral pyridoxine has been described as beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PIGS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_033198.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 22 | 23 | |||
| missense | 3 | 2 | 93 | 10 | 3 | 111 |
| nonsense | 1 | 3 | 2 | 6 | ||
| start loss | 0 | |||||
| frameshift | 1 | 3 | 1 | 5 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 6 | 10 | 97 | 32 | 3 | 148 |
Highest pathogenic variant AF is 0.00002395308
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_149975.1 | 12 | MANE Select | |
| Ensembl | ENSP00000309430.7 | 12 | MANE Select | |
| Ensembl | ENSP00000268758.9 | 2 | Standard | |
| Ensembl | ENSP00000378755.2 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human)
- Attachment of GPI anchor to uPAR
- Post-translational modification: synthesis of GPI-anchored proteins
- Post-translational protein modification
- Metabolism of proteins
Biological Process
- attachment of GPI anchor to protein
Molecular Function
- GPI-anchor transamidase activity
- protein binding
Cellular Component
- endoplasmic reticulum membrane
- membrane
- GPI-anchor transamidase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000308360
- Coding exons
- 12
- Length
- 18490
- Individuals with no LoFs
- 125693
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 55
- Defined
- 125748
- p
- 0.000219
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.780 | 285 | 325 | 0.878 | 0.0000178 | 3564 |
| Missense (PolyPhen) | 65 | 91.769 | 0.7083 | 1036 | ||
| Synonymous | 0.172 | 133 | 136 | 0.981 | 0.00000762 | 1172 |
| Loss of Function | 2.45 | 12 | 25.3 | 0.475 | 0.00000116 | 303 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00014 | 0.00012 | rare |
| Ashkenazi Jewish | 0.00050 | 0.00050 | rare |
| East Asian | 0.00028 | 0.00027 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00028 | 0.00028 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the GPI transamidase complex. Essential for transfer of GPI to proteins, particularly for formation of carbonyl intermediates. {ECO:0000269|PubMed:11483512}.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- LoFtool
- 0.708
- RVIS EVS
- 0.09
- RVIS percentile EVS
- 60.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- H
- Indispensability pred.
- N
- Indispensability score
- 0.421
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |